MTG1
gene geneOn this page
Summary
MTG1 (mitochondrial ribosome associated GTPase 1, HGNC:32159) is a protein-coding gene on chromosome 10q26.3, encoding Mitochondrial ribosome-associated GTPase 1 (Q9BT17). Plays a role in the regulation of the mitochondrial ribosome assembly and of translational activity. It is a selective cancer dependency (DepMap: 21.0% of cell lines).
Enables GTPase activity. Involved in mitochondrial large ribosomal subunit assembly; regulation of mitochondrial translation; and regulation of respiratory system process. Located in mitochondrial inner membrane; mitochondrial ribosome; and nucleoplasm. Is active in mitochondrial matrix.
Source: NCBI Gene 92170 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 78 total
- Cancer dependency (DepMap): dependent in 21.0% of screened cell lines
- MANE Select transcript:
NM_138384
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32159 |
| Approved symbol | MTG1 |
| Name | mitochondrial ribosome associated GTPase 1 |
| Location | 10q26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000148824 |
| Ensembl biotype | protein_coding |
| Entrez | 92170 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 10 protein_coding, 5 retained_intron
ENST00000317502, ENST00000432508, ENST00000460848, ENST00000473735, ENST00000477902, ENST00000492266, ENST00000495014, ENST00000498790, ENST00000851826, ENST00000851827, ENST00000923263, ENST00000923264, ENST00000949007, ENST00000949008, ENST00000949009
RefSeq mRNA: 1 — MANE Select: NM_138384
NM_138384
CCDS: CCDS31320
Canonical transcript exons
ENST00000317502 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001237415 | 133420026 | 133422520 |
| ENSE00001593483 | 133394157 | 133394332 |
| ENSE00003668382 | 133395713 | 133395777 |
| ENSE00003695691 | 133399170 | 133399226 |
| ENSE00003695811 | 133401529 | 133401590 |
| ENSE00003696196 | 133419480 | 133419592 |
| ENSE00003696577 | 133396163 | 133396267 |
| ENSE00003698138 | 133402692 | 133402773 |
| ENSE00003699218 | 133402149 | 133402245 |
| ENSE00003699810 | 133398435 | 133398515 |
| ENSE00003701777 | 133399529 | 133399619 |
Expression profiles
Bgee: expression breadth ubiquitous, 211 present calls, max score 95.64.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 45.3999 / max 362.0980, expressed in 1823 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 107799 | 23.9418 | 1813 |
| 107798 | 20.8553 | 1812 |
| 107800 | 0.6027 | 366 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 95.64 | gold quality |
| metanephros cortex | UBERON:0010533 | 94.95 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.49 | gold quality |
| pancreatic ductal cell | CL:0002079 | 94.45 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 94.36 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.83 | gold quality |
| right testis | UBERON:0004534 | 93.65 | gold quality |
| left testis | UBERON:0004533 | 93.63 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.63 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 93.56 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.53 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 93.44 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 93.35 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 93.32 | gold quality |
| cerebellar cortex | UBERON:0002129 | 93.31 | gold quality |
| body of pancreas | UBERON:0001150 | 93.15 | gold quality |
| granulocyte | CL:0000094 | 93.06 | gold quality |
| sural nerve | UBERON:0015488 | 93.06 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 92.88 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 92.83 | gold quality |
| spleen | UBERON:0002106 | 92.82 | gold quality |
| adrenal cortex | UBERON:0001235 | 92.59 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 92.33 | gold quality |
| adrenal gland | UBERON:0002369 | 92.14 | gold quality |
| right ovary | UBERON:0002118 | 92.05 | gold quality |
| minor salivary gland | UBERON:0001830 | 91.99 | gold quality |
| body of stomach | UBERON:0001161 | 91.97 | gold quality |
| adenohypophysis | UBERON:0002196 | 91.94 | gold quality |
| cerebellum | UBERON:0002037 | 91.81 | gold quality |
| esophagus mucosa | UBERON:0002469 | 91.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.26 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
6 targeting MTG1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4696 | 99.48 | 67.48 | 1040 |
| HSA-MIR-12135 | 98.99 | 70.26 | 1814 |
| HSA-MIR-1237-3P | 98.55 | 67.65 | 1423 |
| HSA-MIR-653-3P | 98.31 | 67.71 | 1542 |
| HSA-MIR-4764-3P | 96.81 | 67.94 | 580 |
| HSA-MIR-3169 | 96.40 | 67.58 | 698 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 21.0% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 5)
- The results suggested that Mtg1 functions with the large subunit of the mitochondrial ribosome, and are involved in both the translation and assembly of respiratory complexes. (PMID:23396448)
- MTG1 establishes a quality control checkpoint in mitoribosome assembly. In conclusion, MTG1 controls mitochondrial translation by coupling mtLSU assembly with intersubunit bridge formation using the intrinsic GEF activity acquired by the mtSSU through mS27, a unique occurrence in translational systems. (PMID:30085276)
- dampening oxidative stress with N-acetylcysteine (NAC) lowered hypertrophy in MTG1 KO to WT levels. Collectively, our data indicate that MTG1 protects against pressure overload-induced cardiac hypertrophy and dysfunction by preserving mitochondrial function and reducing oxidative stress and downstream TAK1 stress signaling. (PMID:30707992)
- Potential pathogenetic link between angiomyofibroblastoma and superficial myofibroblastoma in the female lower genital tract based on a novel MTG1-CYP2E1 fusion. (PMID:34385605)
- Vulvar angiomyofibroblastoma is molecularly defined by recurrent MTG1-CYP2E1 fusions. (PMID:36177509)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mtg1 | ENSDARG00000069386 |
| mus_musculus | Mtg1 | ENSMUSG00000039018 |
| rattus_norvegicus | Mtg1 | ENSRNOG00000018860 |
| drosophila_melanogaster | CG17141 | FBGN0039020 |
| caenorhabditis_elegans | WBGENE00022054 |
Paralogs (6): LSG1 (ENSG00000041802), NOA1 (ENSG00000084092), GNL3L (ENSG00000130119), GNL2 (ENSG00000134697), GNL3 (ENSG00000163938), GNL1 (ENSG00000204590)
Protein
Protein identifiers
Mitochondrial ribosome-associated GTPase 1 — Q9BT17 (reviewed: Q9BT17)
Alternative names: GTP-binding protein 7, Mitochondrial GTPase 1
All UniProt accessions (3): Q9BT17, E7EVK2, U3KQ69
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in the regulation of the mitochondrial ribosome assembly and of translational activity. Displays mitochondrial GTPase activity.
Subunit / interactions. Associates with the mitochondrial ribosome large subunit; the association occurs in a GTP-dependent manner.
Subcellular location. Mitochondrion inner membrane.
Similarity. Belongs to the TRAFAC class YlqF/YawG GTPase family. MTG1 subfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BT17-1 | 1 | yes |
| Q9BT17-2 | 2 |
RefSeq proteins (1): NP_612393* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006073 | GTP-bd | Domain |
| IPR016478 | GTPase_MTG1 | Family |
| IPR019991 | GTP-bd_ribosome_bgen | Family |
| IPR023179 | GTP-bd_ortho_bundle_sf | Homologous_superfamily |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR030378 | G_CP_dom | Domain |
Pfam: PF01926
UniProt features (9 total): binding site 3, splice variant 2, transit peptide 1, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
5 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7O9M | ELECTRON MICROSCOPY | 2.6 |
| 8QSJ | ELECTRON MICROSCOPY | 3 |
| 8PK0 | ELECTRON MICROSCOPY | 3.03 |
| 7O9K | ELECTRON MICROSCOPY | 3.1 |
| 7PD3 | ELECTRON MICROSCOPY | 3.4 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BT17-F1 | 88.13 | 0.65 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (3): 83–86; 153–158; 205
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 132 (showing top):
GOBP_RIBOSOME_BIOGENESIS, GOBP_RESPIRATORY_GASEOUS_EXCHANGE_BY_RESPIRATORY_SYSTEM, GOBP_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS, GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_RESPIRATORY_SYSTEM_PROCESS, GOBP_RIBOSOME_ASSEMBLY, ZHAN_MULTIPLE_MYELOMA_CD1_UP, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GOBP_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY, GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_ORGANELLE_ASSEMBLY, ATGCTGG_MIR338, GOBP_REGULATION_OF_SYSTEM_PROCESS
GO Biological Process (4): regulation of respiratory system process (GO:0044065), regulation of mitochondrial translation (GO:0070129), mitochondrial large ribosomal subunit assembly (GO:1902775), regulation of translation (GO:0006417)
GO Molecular Function (4): GTPase activity (GO:0003924), GTP binding (GO:0005525), nucleotide binding (GO:0000166), protein binding (GO:0005515)
GO Cellular Component (6): nucleoplasm (GO:0005654), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial matrix (GO:0005759), mitochondrial ribosome (GO:0005761), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| respiratory system process | 1 |
| regulation of respiratory gaseous exchange | 1 |
| regulation of system process | 1 |
| regulation of translation | 1 |
| mitochondrial translation | 1 |
| regulation of mitochondrial gene expression | 1 |
| ribosomal large subunit assembly | 1 |
| mitochondrial ribosome assembly | 1 |
| translation | 1 |
| post-transcriptional regulation of gene expression | 1 |
| regulation of protein metabolic process | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrion | 1 |
| intracellular organelle lumen | 1 |
| organellar ribosome | 1 |
| mitochondrial matrix | 1 |
Protein interactions and networks
STRING
2273 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MTG1 | SPRN | Q5BIV9 | 966 |
| MTG1 | MTG2 | Q9H4K7 | 880 |
| MTG1 | MALSU1 | Q96EH3 | 866 |
| MTG1 | GTPBP10 | A4D1E9 | 832 |
| MTG1 | NOA1 | Q8NC60 | 822 |
| MTG1 | MRM1 | Q6IN84 | 814 |
| MTG1 | MTERF4 | Q7Z6M4 | 811 |
| MTG1 | GTPBP4 | Q9BZE4 | 793 |
| MTG1 | NSUN4 | Q96CB9 | 788 |
| MTG1 | MRM2 | Q9UI43 | 764 |
| MTG1 | DDX28 | Q9NUL7 | 740 |
| MTG1 | ERAL1 | O75616 | 734 |
| MTG1 | GTPBP8 | Q8N3Z3 | 700 |
| MTG1 | GTPBP6 | O43824 | 690 |
| MTG1 | MRM3 | Q9HC36 | 611 |
IntAct
47 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HSPD1 | NUDT19 | psi-mi:“MI:0914”(association) | 0.710 |
| MTG1 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT37 | MTG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX2 | MTG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ERICH1 | MTG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIP13 | INTS11 | psi-mi:“MI:0914”(association) | 0.550 |
| BPNT1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| YBEY | NME4 | psi-mi:“MI:0914”(association) | 0.530 |
| ISLR | BCKDK | psi-mi:“MI:0914”(association) | 0.530 |
| ZNRD2 | CCDC85C | psi-mi:“MI:0914”(association) | 0.530 |
| MTG1 | H2BC12L | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNRD2 | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
| ISLR | DDX11L8 | psi-mi:“MI:0914”(association) | 0.350 |
| YBEY | NUDT19 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL12 | psi-mi:“MI:0914”(association) | 0.350 | |
| GRPR | GPR89A | psi-mi:“MI:0914”(association) | 0.350 |
| TRIP13 | METTL8 | psi-mi:“MI:0914”(association) | 0.350 |
| CAMK2D | SETD1A | psi-mi:“MI:0914”(association) | 0.350 |
| HCST | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| PIPSL | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| FTL | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.350 |
| UQCRFS1 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| MALSU1 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| SCGB2A2 | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| CAMK2A | SMCHD1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (169): MTG1 (Two-hybrid), MTG1 (Affinity Capture-MS), MTG1 (Reconstituted Complex), MTG1 (Affinity Capture-MS), MTG1 (Affinity Capture-MS), MTG1 (Affinity Capture-MS), MTG1 (Affinity Capture-MS), MTG1 (Affinity Capture-MS), MTG1 (Affinity Capture-MS), MTG1 (Affinity Capture-MS), MTG1 (Affinity Capture-MS), MTG1 (Affinity Capture-MS), MTG1 (Affinity Capture-MS), MTG1 (Reconstituted Complex), MTG1 (Proximity Label-MS)
ESM2 similar proteins: A4D1E9, A5A6N7, A9JTX2, E3TDS3, F4JJJ3, M1BYJ7, O93545, P00336, P00337, P00341, P07195, P13491, P13743, P16125, P31754, P33571, P42120, P42123, P79912, P79913, Q06849, Q17EJ1, Q28HM1, Q32LU1, Q3MHG6, Q4PS77, Q4R5B6, Q5E9B1, Q5U528, Q6DGK2, Q6DHF7, Q6DIS1, Q7T0W5, Q8K013, Q8R2R6, Q98SK9, Q98SL1, Q9BT17, Q9CY28, Q9LID6
Diamond homologs: A2BPL9, A2BV51, A2C0J7, A2SHB1, A3PBA9, A5CDT2, A5CY46, A5IZG5, A7GGA7, A7ZBS1, A8F732, A8FD69, A8G3A3, A8YTQ7, A8YV35, A9BHZ7, A9JTX2, A9KFU3, A9NDV6, B0B8S4, B0BAF3, B0K530, B0K5N4, B0K8H9, B0KBA1, B0KPJ1, B1JDV4, B1L9N6, B1XXK9, B2J1L2, B2USZ4, B3CR58, B3EMI7, B3QZ96, B5Z7J9, B6IZN3, B6J7Q3, B6JM65, B7GGD6, B7IDZ1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
78 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 62 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2345 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:133394331:GG:G | donor_gain | 1.0000 |
| 10:133394332:GG:G | donor_gain | 1.0000 |
| 10:133395798:G:T | donor_gain | 1.0000 |
| 10:133395814:G:GT | donor_gain | 1.0000 |
| 10:133398429:TTTCA:T | acceptor_loss | 1.0000 |
| 10:133398430:TTCA:T | acceptor_loss | 1.0000 |
| 10:133398431:TCA:T | acceptor_loss | 1.0000 |
| 10:133398432:CA:C | acceptor_loss | 1.0000 |
| 10:133398433:A:AG | acceptor_gain | 1.0000 |
| 10:133398433:AGA:A | acceptor_loss | 1.0000 |
| 10:133398433:AGAA:A | acceptor_loss | 1.0000 |
| 10:133398434:G:GA | acceptor_gain | 1.0000 |
| 10:133398434:G:T | acceptor_loss | 1.0000 |
| 10:133398434:GA:G | acceptor_gain | 1.0000 |
| 10:133398434:GAA:G | acceptor_gain | 1.0000 |
| 10:133398434:GAAA:G | acceptor_gain | 1.0000 |
| 10:133398512:GCAG:G | donor_gain | 1.0000 |
| 10:133398513:CAGG:C | donor_loss | 1.0000 |
| 10:133398514:AG:A | donor_loss | 1.0000 |
| 10:133398515:GGTAG:G | donor_loss | 1.0000 |
| 10:133398517:T:G | donor_loss | 1.0000 |
| 10:133399616:A:T | donor_gain | 1.0000 |
| 10:133402144:CACA:C | acceptor_loss | 1.0000 |
| 10:133402145:A:AG | acceptor_gain | 1.0000 |
| 10:133402145:ACAG:A | acceptor_gain | 1.0000 |
| 10:133402145:ACAGG:A | acceptor_loss | 1.0000 |
| 10:133402146:C:G | acceptor_gain | 1.0000 |
| 10:133402146:CA:C | acceptor_loss | 1.0000 |
| 10:133402147:A:AG | acceptor_gain | 1.0000 |
| 10:133402147:A:AT | acceptor_loss | 1.0000 |
AlphaMissense
2175 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:133394311:T:C | F31L | 0.998 |
| 10:133394313:C:A | F31L | 0.998 |
| 10:133394313:C:G | F31L | 0.998 |
| 10:133396237:G:C | K84N | 0.996 |
| 10:133396237:G:T | K84N | 0.996 |
| 10:133399563:C:A | P152H | 0.996 |
| 10:133399567:C:A | N153K | 0.996 |
| 10:133399567:C:G | N153K | 0.996 |
| 10:133402180:A:C | D202A | 0.996 |
| 10:133396227:T:A | V81D | 0.995 |
| 10:133399572:G:A | G155D | 0.995 |
| 10:133402179:G:C | D202H | 0.995 |
| 10:133402740:T:C | L240P | 0.995 |
| 10:133420089:G:C | R310P | 0.995 |
| 10:133394325:G:A | M35I | 0.994 |
| 10:133394325:G:C | M35I | 0.994 |
| 10:133394325:G:T | M35I | 0.994 |
| 10:133399557:G:A | G150E | 0.994 |
| 10:133399574:A:C | K156Q | 0.994 |
| 10:133399575:A:T | K156M | 0.994 |
| 10:133399584:T:C | L159P | 0.994 |
| 10:133402180:A:G | D202G | 0.994 |
| 10:133402180:A:T | D202V | 0.994 |
| 10:133394308:T:A | W30R | 0.993 |
| 10:133394308:T:C | W30R | 0.993 |
| 10:133395769:G:C | D57H | 0.993 |
| 10:133395770:A:C | D57A | 0.993 |
| 10:133395770:A:G | D57G | 0.993 |
| 10:133395770:A:T | D57V | 0.993 |
| 10:133395773:C:A | A58D | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000059681 (10:133407142 C>A,T), RS1000126153 (10:133419351 G>A), RS1000245596 (10:133399687 C>T), RS1000275977 (10:133412958 G>C), RS1000496844 (10:133394824 C>A,T), RS1000608285 (10:133412594 G>A), RS1000697932 (10:133395515 A>C,T), RS1000775826 (10:133421134 G>GGTGCTCAGTGGCCCCTC), RS1000870046 (10:133414567 T>C), RS1000959523 (10:133422970 T>C), RS1001076096 (10:133408480 C>A,T), RS1001134602 (10:133402887 C>T), RS1001137335 (10:133395595 T>G), RS1001225381 (10:133394606 C>G,T), RS1001234550 (10:133406620 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002463_18 | Systemic lupus erythematosus | 3.000000e-06 |
| GCST003264_213 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004713 | FEV/FVC ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression, decreases expression, affects cotreatment, increases abundance | 5 |
| Valproic Acid | affects cotreatment, increases expression | 4 |
| Cadmium Chloride | decreases expression | 2 |
| cobaltous chloride | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| manganese chloride | increases abundance, affects cotreatment, decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| tamibarotene | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| clothianidin | decreases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | increases expression, affects cotreatment | 1 |
| jinfukang | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic | affects cotreatment, decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cannabidiol | increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Coumestrol | increases expression | 1 |
| Ethinyl Estradiol | decreases expression | 1 |
| Manganese | decreases expression, increases abundance, affects cotreatment | 1 |
| Naled | affects expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Ribonucleotides | affects binding | 1 |
| Rotenone | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | affects expression | 1 |
| Cyclosporine | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.